The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious diseases, and Man’s Best Friend Therapeutics Inc., an animal health company, are entering into an exclusive license agreement for the advancement of immunotherapeutic vaccines for companion and domestic animals based on technology created at Wistar.
A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.
